[Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000503:physiopathology*; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D011804:Quinolines
Zur Wirkung des neuen beta-blockers carteolol (OPC-1085). Verbesserung des Kollateralkreislaufes bei Hunden mit chronischer Koronararterien-Okklusion.